136 related articles for article (PubMed ID: 22932133)
1. [Efficacy and safety analysis with standardized mite allergen subcutaneous immunotherapy in 90 patients with allergic rhinitis].
Li L; Guan GM; Zhu DD; Sha JC; Jin GH; Chen MX; Zhang H; Dong Z
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 47(6):445-8. PubMed ID: 22932133
[TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy of subcutaneous and sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
Zhu L; Zhu LP; Chen RX; Tao QL; Lu JH; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):986-91. PubMed ID: 22336009
[TBL] [Abstract][Full Text] [Related]
3. [Effect and safety analysis of Allergovit standardized mite allergen immunotherapy in patients with allergic rhinitis].
Zhao X; Wu H; Lin L; Liu Q; Li X; Luo B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Oct; 27(20):1128-31. PubMed ID: 24479356
[TBL] [Abstract][Full Text] [Related]
4. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
5. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].
Du X; Shu C; Xu G; Ma M; Song H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in patients with allergic rhinitis].
Li TY; Chen DH; Lin ZB; Xu R
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 46(10):859-62. PubMed ID: 22321427
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
8. Simplified local nasal immunotherapy in mite dust allergic rhinitis.
Bellussi L; Bologna M; Di Stanislao C; Lauriello M; Mezzedimi C; Muzi P; Passàli GC; Passàli D
J Investig Allergol Clin Immunol; 2002; 12(1):42-7. PubMed ID: 12109531
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
[TBL] [Abstract][Full Text] [Related]
10. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sublingual immunotherapy in Asian children.
Park IH; Hong SM; Lee HM
Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1761-6. PubMed ID: 22959336
[TBL] [Abstract][Full Text] [Related]
12. [The effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis].
Fu Z; Lin X; Cai F; Wang G; Deng H; Li Q; Wang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):744-6. PubMed ID: 23213755
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of a once-daily sublingual immunotherapy without escalation regimen in house dust mite-induced allergic rhinitis.
Mun SJ; Shin JM; Han DH; Kim JW; Kim DY; Lee CH; Min YG; Rhee CS
Int Forum Allergy Rhinol; 2013 Mar; 3(3):177-83. PubMed ID: 23044892
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
15. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
[TBL] [Abstract][Full Text] [Related]
16. [Rhinitis in adults].
Kalogjera L
Acta Med Croatica; 2011; 65(2):181-7. PubMed ID: 22359885
[TBL] [Abstract][Full Text] [Related]
17. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
18. [Study on safty of standardized specific mite-allergen immunotherapy to children with allergic rhinitis and/or asthma].
Wu Y; Long Z; Huang Y; Huang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jul; 25(14):641-4. PubMed ID: 22032122
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis.
Riechelmann H; Schmutzhard J; van der Werf JF; Distler A; Kleinjans HA
Am J Rhinol Allergy; 2010; 24(5):e104-9. PubMed ID: 21244725
[TBL] [Abstract][Full Text] [Related]
20. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
